RSS 1.0Bereiche des edoc-Servers
Amtliche Bekanntmachungen/KommissionsveröffentlichungenArtikel in FachzeitschriftenDigitale SurveillanceForschungsdatenFortlaufende VeröffentlichungenHistorische Schriften aus dem Robert Koch-InstitutInformationen über das InstitutQualifikationsarbeiten
Neuzugänge
-
2024-02-29ZeitschriftenartikelICTV Virus Taxonomy Profile: Kolmioviridae 2024 Kolmioviridae is a family for negative-sense RNA viruses with circular, viroid-like genomes of about 1.5–1.7 kb that are maintained in mammals, amphibians, birds, fish, insects and reptiles. Deltaviruses, for instance, can ...
-
2024-10-03ZeitschriftenartikelTargeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs Spread of multidrug-resistant Pseudomonas aeruginosa strains threatens to render currently available antibiotics obsolete, with limited prospects for the development of new antibiotics. Lytic bacteriophages, the viruses ...
-
2024-03-11ZeitschriftenartikelMortality of type 2 diabetes in Germany: additional insights from Gompertz models Aims: The Gompertz law of mortality proclaims that human mortality rates in middle to old ages grow log-linearly with age and this law has been confirmed at multiple instances. We investigated if diabetes mortality in ...
-
2024-07-08ZeitschriftenartikelCorrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)]
-
2024-06-04ZeitschriftenartikelEffectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024 In autumn 2023, European vaccination campaigns predominantly administered XBB.1.5 vaccine. In a European multicentre study, we estimated 2023 COVID-19 vaccine effectiveness (VE) against laboratory-confirmed symptomatic ...